Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Frequency in Treatment-Resistant Depression
NCT00646087Phase 4Withdrawn
- Sponsor
- Essentia Health
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by Essentia Health. Planned start Mar 2008; status: withdrawn.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00646087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646087.